Literature DB >> 20948433

14G2a anti-GD2 crossreactivity with the CD166 antigen.

Vaidehi Agrawal, Arthur Edward Frankel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20948433     DOI： 10.1097/CJI.0b013e3181f3bf36

Source DB:  PubMed          Journal:  J Immunother        ISSN： 1524-9557            Impact factor:   4.456


× No keyword cloud information.
  3 in total

1.  Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells.

Authors:  Sonia Bergante; Enrica Torretta; Pasquale Creo; Nadia Sessarego; Nadia Papini; Marco Piccoli; Chiara Fania; Federica Cirillo; Erika Conforti; Andrea Ghiroldi; Cristina Tringali; Bruno Venerando; Adalberto Ibatici; Cecilia Gelfi; Guido Tettamanti; Luigi Anastasia
Journal:  J Lipid Res       Date:  2014-01-21       Impact factor: 5.922

2.  The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.

Authors:  S Kailayangiri; B Altvater; J Meltzer; S Pscherer; A Luecke; C Dierkes; U Titze; K Leuchte; S Landmeier; M Hotfilder; U Dirksen; J Hardes; G Gosheger; H Juergens; C Rossig
Journal:  Br J Cancer       Date:  2012-02-28       Impact factor: 7.640

3.  Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.

Authors:  Igor I Doronin; Polina A Vishnyakova; Irina V Kholodenko; Eugene D Ponomarev; Dmitry Y Ryazantsev; Irina M Molotkovskaya; Roman V Kholodenko
Journal:  BMC Cancer       Date:  2014-04-28       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.